These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 33190687)
21. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK. Tiet MY; AlShaikh N BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309 [TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Coen M; Jeanson G; Culebras Almeida LA; Hübers A; Stierlin F; Najjar I; Ongaro M; Moulin K; Makrygianni M; Leemann B; Kronig I; Bertrand J; Reny JL; Schibler M; Serratrice J Brain Behav Immun; 2020 Jul; 87():111-112. PubMed ID: 32360440 [No Abstract] [Full Text] [Related]
23. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report. Riva N; Russo T; Falzone YM; Strollo M; Amadio S; Del Carro U; Locatelli M; Filippi M; Fazio R J Neurol; 2020 Sep; 267(9):2492-2494. PubMed ID: 32458192 [No Abstract] [Full Text] [Related]
24. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection. Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924 [TBL] [Abstract][Full Text] [Related]
25. Antibodies against nodo-paranodal proteins are not present in genetic neuropathies. Martín-Aguilar L; Pascual-Goñi E; Lleixà C; Frasquet M; Argente H; Cano-Abascal A; Diaz-Manera J; Cortés-Vicente E; Pelayo-Negro AL; Sevilla T; Rojas-García R; Querol L Neurology; 2020 Jul; 95(4):e427-e433. PubMed ID: 32102977 [TBL] [Abstract][Full Text] [Related]
26. Guillain-Barré syndrome following COVID-19: new infection, old complication? Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166 [No Abstract] [Full Text] [Related]
27. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. Uncini A; Vallat JM; Jacobs BC J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289 [TBL] [Abstract][Full Text] [Related]
28. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Assini A; Benedetti L; Di Maio S; Schirinzi E; Del Sette M Neurol Sci; 2020 Jul; 41(7):1657-1658. PubMed ID: 32468450 [No Abstract] [Full Text] [Related]
29. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports. Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610 [TBL] [Abstract][Full Text] [Related]
30. A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID-19. Reyes C; Ornelas CJ; Rollins-Raval MA; Subbaswamy AV; Phillips JP; Raval JS J Clin Apher; 2020 Aug; 35(4):374-375. PubMed ID: 32767584 [No Abstract] [Full Text] [Related]
31. Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report. Rana S; Lima AA; Chandra R; Valeriano J; Desai T; Freiberg W; Small G J Clin Neuromuscul Dis; 2020 Jun; 21(4):240-242. PubMed ID: 32453100 [No Abstract] [Full Text] [Related]
32. Spectrum of Neurological Manifestations in Covid-19: A Review. Garg RK Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664 [TBL] [Abstract][Full Text] [Related]
33. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817 [TBL] [Abstract][Full Text] [Related]
34. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2. Bracaglia M; Naldi I; Govoni A; Brillanti Ventura D; De Massis P J Neurol; 2020 Nov; 267(11):3166-3168. PubMed ID: 32588185 [No Abstract] [Full Text] [Related]
35. Guillain-Barré syndrome associated with COVID-19 disease. Korem S; Gandhi H; Dayag DB BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958554 [TBL] [Abstract][Full Text] [Related]
36. Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies. Yu RK; Ariga T; Usuki S; Kaida K Adv Exp Med Biol; 2011; 705():349-65. PubMed ID: 21618117 [No Abstract] [Full Text] [Related]
37. Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication. Webb S; Wallace VC; Martin-Lopez D; Yogarajah M BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32540883 [TBL] [Abstract][Full Text] [Related]
39. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection. Agha Abbaslou M; Karbasi M; Mozhdehipanah H Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316 [TBL] [Abstract][Full Text] [Related]
40. Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies. Kuwabara S; Misawa S; Mori M J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):707. PubMed ID: 25758172 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]